Dan Buettner
Showing 1–4 of 4 transcripts.
- Milken Institute59 min
The Roadmap to Longevity | Global Conference 2025
Gadi Schwartz, Dan Buettner, Laura Deming, Richard Isaacson, Eric Verdin, Vonda Wright
Panels including Dan Buettner, Laura Deming, and Dr. Eric Verdin emphasized a paradigm shift from extending mere life span to maximizing health and brain span through lifestyle interventions that determine 93% of longevity outcomes. While no single "hack" exists, experts project that combining optimized nutrition, walkable urban design, and emerging precision medicine could push healthy life expectancy to 90–95 years, with the first FDA-approved longevity drug anticipated within the next five years. Despite this potential for breakthrough therapies, the consensus highlights a critical funding crisis threatening US biomedical research and calls for systemic reforms to democratize access to preventive care rather than reactive sick care.
- Milken Institute59 min
Longevity Lab: Can You Live to 100? | Global Conference 2024
Allison Aubrey, James Bethell, Dan Buettner, Peter Diamandis, Kristen Fortney, Lloyd Minor
A panel of scientists and policymakers discusses converging strategies to achieve longevity escape velocity through the integration of AI-driven biotech, emerging drugs like rapamycin and GLP-1 agonists, and preventative Blue Zone principles that emphasize environmental design over individual willpower. With the XPRIZE Healthspan Competition challenging teams to reverse functional aging within a decade and healthcare systems pivoting from sick care to community-based prevention, the dialogue highlights a transition toward treating aging as a manageable biological process rather than an inevitable decline. While optimistic projections suggest widespread adoption of anti-aging therapies within twenty years, experts caution that true success requires balancing pharmacological interventions with social determinants of health to ensure extended healthspan alongside increased lifespan.
- Milken Institute56 min
The City for All Ages: Harnessing the Promise of Longevity
James Anderson, Dan Buettner, Carol Coletta, Rodney Slater, Jan Vapaavuori, Jim Anderson
Leading urban experts and policymakers converge to address the unprecedented demographic shift where the global population over 65 now exceeds those under 5 by advocating for built environment interventions over individual behavioral changes. Drawing on longevity strategies from Blue Zones and Helsinki's intergenerational housing models, the panel proposes that mayors and civic leaders actively redesign cities to make healthy choices the default option through walkability, social integration, and regulatory nudge policies. These initiatives aim to transform the "silver economy" into a catalyst for civic innovation, ensuring that aging populations remain healthy, employed, and socially connected while reducing the strain on healthcare systems.
- Milken Institute57 min
Want to Live to a Healthy 100?
Paul Irving, Elizabeth Blackburn, Dan Buettner, Laura Deming, Arianna Huffington
Panelists including Dan Buettner, Liz Blackburn, and Arianna Huffington synthesized data on Blue Zone environments, telomere biology, and stress management to redefine longevity as an ecosystem driven by social connection, plant-based diets, and natural movement rather than individual willpower. The discussion highlighted that while specific biological markers like telomere length strongly predict mortality, systemic factors such as zip code and access to healthy environments create a twenty-year life expectancy gap that current healthcare spending fails to address. To bridge this divide, the experts advocated for a policy shift toward the "Wisdom Quotient" and environmental redesign, aiming to compress morbidity and democratize healthspan across all demographics.